Synonyms: BAY293 | compound 23 [PMID: 30683722]
Compound class:
Synthetic organic
Comment: BAY-293 (compound 23) inhibits RAS pathway signalling by disrupting the protein-protein interaction between the RAS GTPase and its nucleotide exchange factor SOS1 [1]. This mechanism mediates an antiproliferative effect. It is suitable as a pharmacological tool to investigate the potential of KRAS/SOS1 modulation in treating proliferative diseases, and it is functional for all KRAS variants.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
BAY-293 prevents the formation of the KRAS-SOS1 complex and thereby blocks reloading of KRAS with GTP (i.e. blocks RAS activation) [1]. The reference article reports that the (R)-enantiomer of BAY-293 binds ~100-fold more strongly to SOS1 than the (S)-enantiomer |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|